Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The reduced folate carrier (RFC, SLC19A1), thiamine transporter-1 (ThTr1, SLC19A2) and thiamine transporter-2 (ThTr2, SLC19A3) evolved from the same family of solute carriers. SLC19A1 transports folates but not thiamine. SLC19A2 and SLC19A3 transport thiamine but not folates. SLC19A1 and SLC19A2 deliver their substrates to systemic tissues; SLC19A3 mediates intestinal thiamine absorption. The proton-coupled folate transporter (PCFT, SLC46A1) is the mechanism by which folates are absorbed across the apical-brush-border membrane of the proximal small intestine. Two folate receptors (FOLR1 and FOLR2) mediate folate transport across epithelia by an endocytic process. Folate transporters are routes of delivery of drugs for the treatment of cancer and inflammatory diseases. There are autosomal recessive disorders associated with mutations in genes encoded for SLC46A1 (hereditary folate malabsorption), FOLR1 (cerebral folate deficiency), SLC19A2 (thiamine-responsive megaloblastic anemia), and SLC19A3 (biotin-responsive basal ganglia disease).

Original languageEnglish (US)
Pages (from-to)373-385
Number of pages13
JournalMolecular Aspects of Medicine
Volume34
Issue number2-3
DOIs
StatePublished - Apr 2013

Fingerprint

Folic Acid Transporters
Thiamine
Folic Acid
Proton-Coupled Folate Transporter
Reduced Folate Carrier Protein
Thiamine Deficiency
Megaloblastic Anemia
Intestinal Absorption
Microvilli
Brushes
Small Intestine
Biotin
Epithelium
Genes
Mutation
Tissue
Membranes

Keywords

  • Folate
  • Folate receptor
  • Hereditary folate malabsorption
  • SCL19A1
  • SCL46A1
  • SLC19A2
  • SLC19A3
  • Thiamine
  • Thiamine-responsive megaloblastic anemia

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry
  • Medicine(all)

Cite this

@article{b7ccd859ad2f4f1e95273790a18ccee3,
title = "Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors",
abstract = "The reduced folate carrier (RFC, SLC19A1), thiamine transporter-1 (ThTr1, SLC19A2) and thiamine transporter-2 (ThTr2, SLC19A3) evolved from the same family of solute carriers. SLC19A1 transports folates but not thiamine. SLC19A2 and SLC19A3 transport thiamine but not folates. SLC19A1 and SLC19A2 deliver their substrates to systemic tissues; SLC19A3 mediates intestinal thiamine absorption. The proton-coupled folate transporter (PCFT, SLC46A1) is the mechanism by which folates are absorbed across the apical-brush-border membrane of the proximal small intestine. Two folate receptors (FOLR1 and FOLR2) mediate folate transport across epithelia by an endocytic process. Folate transporters are routes of delivery of drugs for the treatment of cancer and inflammatory diseases. There are autosomal recessive disorders associated with mutations in genes encoded for SLC46A1 (hereditary folate malabsorption), FOLR1 (cerebral folate deficiency), SLC19A2 (thiamine-responsive megaloblastic anemia), and SLC19A3 (biotin-responsive basal ganglia disease).",
keywords = "Folate, Folate receptor, Hereditary folate malabsorption, SCL19A1, SCL46A1, SLC19A2, SLC19A3, Thiamine, Thiamine-responsive megaloblastic anemia",
author = "Rongbao Zhao and Goldman, {I. David}",
year = "2013",
month = "4",
doi = "10.1016/j.mam.2012.07.006",
language = "English (US)",
volume = "34",
pages = "373--385",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",
number = "2-3",

}

TY - JOUR

T1 - Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors

AU - Zhao, Rongbao

AU - Goldman, I. David

PY - 2013/4

Y1 - 2013/4

N2 - The reduced folate carrier (RFC, SLC19A1), thiamine transporter-1 (ThTr1, SLC19A2) and thiamine transporter-2 (ThTr2, SLC19A3) evolved from the same family of solute carriers. SLC19A1 transports folates but not thiamine. SLC19A2 and SLC19A3 transport thiamine but not folates. SLC19A1 and SLC19A2 deliver their substrates to systemic tissues; SLC19A3 mediates intestinal thiamine absorption. The proton-coupled folate transporter (PCFT, SLC46A1) is the mechanism by which folates are absorbed across the apical-brush-border membrane of the proximal small intestine. Two folate receptors (FOLR1 and FOLR2) mediate folate transport across epithelia by an endocytic process. Folate transporters are routes of delivery of drugs for the treatment of cancer and inflammatory diseases. There are autosomal recessive disorders associated with mutations in genes encoded for SLC46A1 (hereditary folate malabsorption), FOLR1 (cerebral folate deficiency), SLC19A2 (thiamine-responsive megaloblastic anemia), and SLC19A3 (biotin-responsive basal ganglia disease).

AB - The reduced folate carrier (RFC, SLC19A1), thiamine transporter-1 (ThTr1, SLC19A2) and thiamine transporter-2 (ThTr2, SLC19A3) evolved from the same family of solute carriers. SLC19A1 transports folates but not thiamine. SLC19A2 and SLC19A3 transport thiamine but not folates. SLC19A1 and SLC19A2 deliver their substrates to systemic tissues; SLC19A3 mediates intestinal thiamine absorption. The proton-coupled folate transporter (PCFT, SLC46A1) is the mechanism by which folates are absorbed across the apical-brush-border membrane of the proximal small intestine. Two folate receptors (FOLR1 and FOLR2) mediate folate transport across epithelia by an endocytic process. Folate transporters are routes of delivery of drugs for the treatment of cancer and inflammatory diseases. There are autosomal recessive disorders associated with mutations in genes encoded for SLC46A1 (hereditary folate malabsorption), FOLR1 (cerebral folate deficiency), SLC19A2 (thiamine-responsive megaloblastic anemia), and SLC19A3 (biotin-responsive basal ganglia disease).

KW - Folate

KW - Folate receptor

KW - Hereditary folate malabsorption

KW - SCL19A1

KW - SCL46A1

KW - SLC19A2

KW - SLC19A3

KW - Thiamine

KW - Thiamine-responsive megaloblastic anemia

UR - http://www.scopus.com/inward/record.url?scp=84875206514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875206514&partnerID=8YFLogxK

U2 - 10.1016/j.mam.2012.07.006

DO - 10.1016/j.mam.2012.07.006

M3 - Article

VL - 34

SP - 373

EP - 385

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

IS - 2-3

ER -